Tuberculosis Manual Contents

Colorado.gov

Colorado Department of Public Health and Environment

Tuberculosis Manual Contents

The information listed below is provided in a Portable Document Format (PDF) file. This can be directly downloaded and stored on your disk or viewed using the free Adobe Reader.

Table of Contents (2004 Revision)

Section 1 Skin Testing

A. Who to test (Page 1)
B. How to Apply the TB Skin Test (Page 3)
C. How to Read/Measure Test Results (Page 5)
D. How to Interpret Test Results (Page 7)
E. BCG Vaccine (Page 9-11)
F. What to do After Interpreting the Skin Test (Page 11)
G. Two-Step TB Skin Testing (Page 13)
H. Anergy Testing (Page 15)
I. References and Resources (Page 16)

Section 2 Latent Tuberculosis Infection (LTBI)

A. Who is Eligible for Treatment of Latent TB Infection (LBTI) (Page 1)
B. How to Administer LBTI (Page 3)
C. Recommended LTBI Drug Treatment Regimens & Dosages (Page 8)
D. How to Monitor for Side Effects (Page 10)
E. How to Monitor for Compliance with IPT (Page 12)
F. References and Resources (Page 13)

Section 3 Active TB

A. How to Diagnose (Page 1)
B. When is an Active Case Contagious (Page 6)
C. Quarantine (Page 7)
D. Transmission Prevention Precautions (Page 10)
E. How to Treat Active TB-Basic Guidelines (Page 15)
F. Treatment Regimens and Doses of Anti-Tuberculosis Drugs (Page 19)
G. TB Treatment in Special Situations (Page 27)
H. TB Drugs—Adverse Reactions and Monitoring (Page 30)
I. Management of Patients With Adverse Reactions to TB Drugs (Page 35)
J. Drug-Resistant TB (Page 46)
K. How to Motivate People to Comply with Therapy (Page 48)
L. Contact Investigation (Page 52)
M. Post Treatment Evaluation and Follow-up (Page 64)
N. Non-Tuberculous Mycobacteria (Page 65)
O. Specimen Collection and Transportation (Page 68)
P. References and Resources (Page 72)

Section 4 Reporting Procedures

A. What to Report (Page 1)
B. Who to Notify Regarding Active/Suspect TB (Page 3)
C. References and Resources (Page 4)

Section 5 Administrative Issues

A. How to Obtain...

1.Anti-tuberculosis Medications (Page 1)
2.Bacteriology Services (Page 1)
3.Chest X-rays (Page 2)
4.Directly Observed Therapy (Page 3)
5.Effective Language Interpreters (Page 3)
6.Other Laboratory Services (Page 3)
7.Patient and Provider Education Materials (Page 4)
8.Skin Testing Materials (Page 4)

B. TB Program Contracting and Reimbursement (Page 5)
C. Forms (see appendix below for link to Forms) (Page 12)
D. Record Retention (Page 17)
E. Technical Assistance (Page 18)
F. Educational Materials (Page 19)
G. Reference and Resources (Page 25)

Section 6 TB and HIV

A. General Comments of TB and HIV

1. When to test for HIV Infection (Page 1)
2. Tuberculosis Skin Testing in HIV Infected Individuals (Page 1)

B. HIV Patients with Latent TB Infections

1. Who is Eligible for Treatment of LTBI? (Page 2)
2. Treatment of LTBI in Patients With HIV (Page 2)
3. Treatment Options for LTBI in Patients with HIV (Page 3)
4. Special Situations (Page 4)
5. Monitoring Patients with HIV on Treatment for LTBI (Page 4)
6. Monitoring Compliance with DOPT (Page 4)

C. HIV Patients with Active TB

7.    General Comments (Page 5)
8.    Basic Guidelines for Patients with Active TB and HIV (Page 6)
9.    Dosage and Treatment Schedules for Patients with HIV and Active TB (Page 8)
10. Dosages and Adverse Reactions to TB Medications (Page 9)
11. Paradoxical Reactions (Page 10)
12. Special Situations (Page 10)
13. Infection Control (Page 11)

C. References and Resources (see appendix below for Resources links) (Page 12)